AlzeCure is sponsored by           

AlzeCure Awarded Alzheimer’s Drug Discovery Foundation Grant

AlzeCure Foundation today announced that the Alzheimer’s Drug Discovery Foundation (ADDF) awarded it a USD 456,905 grant to support the further development of AlzeCure’s small molecule neurorestorative project. The new drug candidate, currently in late discovery phase, will stimulate multiple neurotrophic signaling pathways in the brain, leading to restoration of neuronal function and improved cognition in Alzheimer’s disease patients. (2015-11-04)

Download the PDF file of the Press Release

See announcement from the Alzheimer’s Drug Discovery Foundation (ADDF)